PlainRecalls
LowClass IIITerminated

FDA Food recall · Reported May 1, 2013

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.

Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.

Recall #
F-1338-2013
Affected scope
4571 bottles.
Initiated
April 15, 2013
Compiled from official public sources by the editorial team.
Verify with FDA Food →
View my saved recalls

Nexgen Pharma, Inc. recalled Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes C… - a low-severity action.

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes C… was recalled by Nexgen Pharma, Inc. in May 1, 2013. Reason: Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsu…. Check the official notice for the remedy. Verify recall #F-1338-2013 with the FDA Food before acting.

The recall

Nexgen Pharma, Inc. issued this low-severity FDA Food recall-Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsu….

Low
severity level
Class III
classification
May 1, 2013
reported

Sourced from official FDA Food enforcement records. Verify recall #F-1338-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Food action (record #F-1338-2013) was formally reported on May 1, 2013, with the manufacturer initiating the action on April 15, 2013. It is classified under Low severity (Class III), with a current status of Terminated. Nexgen Pharma, Inc. is listed as the recalling firm, operating out of Colorado Springs, CO. Federal records list the affected scope as 4571 bottles..

The documented reason for this recall is: Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient. Distribution data in the federal record shows the product reached: Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Dietary Supplements recalls over time

Where this recall sits in its category - 2,002 dietary supplements recalls on record

-1000100200300400 20072010201320162019202220252026 9
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Low

Affected scope

4571 bottles.

Related Recalls

6

6 from same agency

Product description

Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.

Reason for recall

Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.

Recall Profile

Structured summary of the FDA Food recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Low (Class III)
Status Terminated
Recall number F-1338-2013
Date reported May 1, 2013
Date initiated April 15, 2013
Recalling firm Nexgen Pharma, Inc.
Firm location Colorado Springs, CO
Affected scope 4571 bottles.
Distribution Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands).

Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (F-1338-2013) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Food before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.. Recalled by Nexgen Pharma, Inc.. Units affected: 4571 bottles..
Why was this product recalled?
Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient.
Which agency issued this recall?
This recall was issued by the FDA Food on May 1, 2013. Severity: Low. Recall number: F-1338-2013.
Where was the recalled product distributed?
Distribution: Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands)..
How do I check if my product is affected by a recall?
Check the product description and recall number (F-1338-2013) against your product. Visit the official FDA Food website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
What are the health risks of consuming a recalled food product?
Recalled food products may contain contaminants, undeclared allergens, or harmful bacteria such as Salmonella, Listeria, or E. coli. Consuming these products can cause foodborne illness ranging from mild gastrointestinal symptoms to serious conditions requiring hospitalization. If you have consumed a recalled food product and experience symptoms, contact your healthcare provider and report to the FDA via MedWatch.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Blue Bull Extreme Male Enhancement Supplement, total of 15 … →

Browse all Dietary Supplements recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported May 1, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.